Mineralocorticoid receptor antagonism reverses diabetes-related coronary vasodilator dysfunction: A unique vascular transcriptomic signature-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Mineralocorticoid receptor antagonism reverses diabetes-related coronary vasodilator dysfunction: A unique vascular transcriptomic signature

Published:2018-08 Issue: Volume:134 Page:100-108
ISSN:1043-6618
Container-title:Pharmacological Research
language:en
Short-container-title:Pharmacological Research

Author:

Brown Scott M.,Meuth Alex I.,Davis J. Wade,Rector R. Scott,Bender Shawn B.

Funder

Department of Veterans Affairs BLR&D

National Institutes of Health

University of Missouri Department of Medicine Research Council

Publisher

Elsevier BV

Subject

Pharmacology

Reference53 articles.

1. A novel paradigm for heart failure with preserved ejection fraction: comorbidities drive myocardial dysfunction and remodeling through coronary microvascular endothelial inflammation;Paulus;J. Am. Coll. Cardiol.,2013

2. Interaction of impaired coronary flow reserve and cardiomyocyte injury on adverse cardiovascular outcomes in patients without overt coronary artery disease;Taqueti;Circulation,2015

3. Association between coronary vascular dysfunction and cardiac mortality in patients with and without diabetes mellitus;Murthy;Circulation,2012

4. Treatment strategies in coronary microvascular dysfunction: a systematic review of interventional studies;Suhrs;Microcirculation,2017

5. Mineralocorticoid receptor antagonism treats obesity-associated cardiac diastolic dysfunction;Bender;Hypertension,2015

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Expanding landscape of coronary microvascular disease in co-morbid conditions: Metabolic disease and beyond;Journal of Molecular and Cellular Cardiology;2024-07

2. Effect of esaxerenone on circulating microparticles and vascular endothelial function in diabetic mice;2024-05-08

3. Endothelial cell dysfunction in cardiac disease: driver or consequence?;Frontiers in Cell and Developmental Biology;2023-10-25

4. A Selective Mineralocorticoid Receptor Blocker, Esaxerenone, Attenuates Vascular Dysfunction in Diabetic C57BL/6 Mice;Journal of Atherosclerosis and Thrombosis;2023-04-01

5. Multi-omic analysis of the cardiac cellulome defines a vascular contribution to cardiac diastolic dysfunction in obese female mice;Basic Research in Cardiology;2023-03-29

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3